FDA melamine alert
This article was originally published in The Tan Sheet
Executive Summary
On Nov. 12, FDA issued an import alert ordering all milk products, milk-derived ingredients and finished food products with milk from China be detained without physical examination due to the possible presence of melamine or melamine analogs. To secure release of shipments, importers must provide results of a third-party lab analysis verifying the absence of melamine and cyanuric acid, or documentation showing the product contains no milk or milk-derived ingredients. FDA also issued an interim safety and risk assessment of melamine in human food, saying in a Nov. 13 Federal Register notice it cannot establish a safe level of melamine and its analogues in infant formula. In foods for older children and adults, levels of melamine and melamine-related compounds below 2.4 ppm do not raise public health concerns, FDA says. The agency adds it does not approve melamine use in direct addition to food or as a fertilizer in the U.S. Comments on the paper, which was drafted after melamine-tainted infant formula caused 13,000 hospitalizations and three deaths. Comments are due Jan. 12 (1"The Tan Sheet" Sept. 15, 2008, In Brief)
You may also be interested in...
Melamine In U.S. Could Pose More Risk To Food Safety Regime Than Infants
FDA says trace amounts of melamine found in U.S.-manufactured infant formula poses no danger, but the discovery will likely lead to a renewed push for food safety oversight and possibly for a separate food safety agency
FDA warns on China formula
Milk-based infant formula manufactured in China may be contaminated with melamine, which raises the protein profile of dairy products and may have contributed to reports of kidney stones in Chinese infants, FDA says Sept. 12. The agency says companies approved for marketing milk-based formula in the U.S. are not importing materials from China, though officials are investigating whether Chinese infant formula is being sold in Asian specialty markets inside the U.S. In its same-day health information advisory, FDA requests the help of states in removing Chinese infant formula products from store shelves. In April 2007, melamine-tainted Chinese pet food caused FDA to issue an import alert on vegetable proteins from China (1"The Tan Sheet" May 21, 2007, p. 6)
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”